Chordate Medical Holding AB

Equities

CMH

SE0009495559

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm Other stock markets 06:19:58 2024-05-16 am EDT			5-day change	1st Jan Change
0.0546 ^SEK	+3.80%		-14.69%	-65.96%

May. 07	Chordate Medical Receives Patent Approval in the US	CI
Mar. 22	Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine

January 30, 2024 at 03:25 am EST

Chordate Medical has signed an agreement with another clinic for the Ozilia treatment for chronic migraine. The client is a specialist clinic in Munich, and Chordate's market consultants in Germany have been handling the processing. In November 2023, Chordate Medical entered into an agreement with a specialist clinic in Hamburg for Ozilia.

Latest news about Chordate Medical Holding AB

Chordate Medical Receives Patent Approval in the US	May. 07	CI
Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 22	CI
Chordate Medical Gains EU Patent for Chronic Migraine Treatment	Feb. 02	MT
Chordate Medical Holding AB Announces the European Patent Office Grants New Patent	Feb. 02	CI
Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine	Jan. 30	CI
Chordate Medical Completes Training of Clinic Staff and Assists in Initiation of Treatment for First Three Patients at the Private Clinic in Hamburg	Jan. 10	CI
Chordate Medical Holding AB Announces First Patients Included in the Post-Market Study PM010	Dec. 21	CI
Chordate Medical Holding AB Announces First Patient Included in the Company's Open Pilot Study PM009	Dec. 04	CI
Chordate Medical Holding AB Receives First Installation of the Ozilia Migraine Treatment at a Private Clinic in Hamburg	Nov. 28	CI
Chordate Medical Holding AB Announces Post-Market Study of Chordate's Ozilia® Migraine Treatment Has Commenced in Four Different Markets	Nov. 10	CI
Chordate Medical Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Oct. 31	CI
Chordate Medical Trademarks Migraine Treatment Ozilia in EU	23-10-27	MT
Chordate Medical Receives Registration of the Tradark Ozilia	23-10-27	CI
Chordate Medical Holding AB Introduces New Trademark for Migraine Treatment: Ozilia? - Migraine Relief	23-09-11	CI
Chordate Medical Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-30	CI
Chordate Medical Holding AB Announces Complete Study Results from Migraine Study Submitted to Scientific Journal	23-08-21	CI
Otto Skolling Elected to Chordate Medical's Board	23-06-15	CI
Study Shows Positive Effects of Chordate Medical's Treatment for Allergic Rhinitis	23-05-29	MT
Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Chordate Medical Holding AB Appoints Otto Skolling as New Vice Chairman of the Board of Directors	23-05-11	CI
UK's National Health Service Grants Ethical Approval for Chordate Medical Migraine Study	23-05-05	MT
NHS Gives Ethical Approval for Chordate's New Migraine Study	23-05-05	CI
Chordate Medical Presents Study Results for the American Headache Society	23-04-19	CI
Chordate Medical Holding AB (Publ.) Announces the Primary Results from the Migraine Study Pm007 - Kinetic Oscillation Stimulation for the Treatment of Chronic Migraine	23-04-13	CI

Chart Chordate Medical Holding AB

Duration

Period

More charts

Company Profile

Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Companyâs headquartered is located in Kista, Sweden.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
CHORDATE MEDICAL HOLDING AB	-65.96%	2.4M
THERMO FISHER SCIENTIFIC	+12.85%	229B
DANAHER CORPORATION	+13.88%	195B
INTUITIVE SURGICAL, INC.	+18.39%	142B
BOSTON SCIENTIFIC CORPORATION	+28.78%	109B
SIEMENS HEALTHINEERS AG	+2.47%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+18.24%	54.33B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.04%	52.09B
AGILENT TECHNOLOGIES, INC.	+10.83%	45.15B
GE HEALTHCARE TECHNOLOGIES INC.	+5.94%	37.39B

Other Advanced Medical Equipment & Technology